Clalit
Medicine’s preemptive strike
How AI quietly changes healthcare in Israel
Six months of a successful pilot at Clalit: X-Ray service at the patient’s home
Emergency teams on alert as Storm Byron brings flooding risks across Israel
President Herzog Commends Sylvan Adams for $100 Million Gift to Rebuild Soroka Medical Center
Gaza border families invited to the Negev to relieve stress
Meir Tzur, head of the Central Arava Regional Council, said that he hopes that they feel safe and calm away from the hustle and bustle.
Drinking green tea can have dangerous consequences - Israeli study
Researchers from Israel's Kaplan Medical Center discovered that drinking too much green tea can cause significant damage to the liver.
Israeli Meir Medical Center welcomes four sets of twins in 24 hours
Eight bundles of joy were successfully delivered at a Clalit-affiliated hospital in Kfar Saba.
Omicron booster vaccine reduces COVID hospitalization, death among elderly
Clalit study is the first in the world to prove new reformulated Omicron vaccine protects the elderly and immunocompromised from hospitalization and death.
First comprehensive study on monkeypox vaccine efficacy conducted in Israel
Researchers in Israel tested the effectiveness of giving a single dose of the vaccine to prevent cases of symptomatic monkeypox infection.
Clalit gives mascot a baseball cap as Deri takes over Health Ministry
The mascot's creator, Daniela London-Dekel, responded: "If it were up to me, Hamoodi would receive the new health minister with two hands outstretched forward with prison uniforms."
Healthcare 2040: Could doctors predict your medical future?
Effectively collaborating with computers could help reduce errors and allow healthcare to shift from supplying patient-level, reactive therapeutics to predictive, proactive and preventative care.
Paxlovid reduces risk of COVID-19 death by 81%, Clalit study shows
So far, over 30,000 COVID-19 patients in Israel have been treated with the anti-viral Paxlovid drug.
Fourth coronavirus vaccine dose lowers mortality risk fourfold - study
Patients who received the fourth dose were 76% less likely to die compared to those who received just the third dose.
Essence Group - Providing innovative personal protection technologies globally
Essence Group, is a leading technology company, which develops cloud-based, end-to-end security and healthcare solutions that protect people while they’re at work and at home.
